Imugene delighted as first cohort 3 patient dosed in CHECKvacc trial

(4:45)

Imugene’s $20 million boost and cancer trial updates

(7:42)

Imugene’s $20 million boost and cancer trial updates

(7:42)

Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success

(16:2)

Imugene's HER-Vaxx Immunotherapy Treatment: Explained

(3:15)

Changing the lives of cancer patients | Dr Leslie Chong of Imugene | ASX CEO Connect Series

(29:22)

Imugene Officially Announce Their HER-Vaxx Trial Results

(8:59)

Imugene Investor Presentation | Non-deal Roadshow 2023 Australia

(44:28)

Interview With The CF33 Oncolytic Virus Inventor - Imugene (IMU)

(20:11)

Imugene featured on Fox Business's 'Trending Today' as a trailblazer in the biotechnology industry.

(4:53)

'The Why' | Imugene, Developing Cancer Immunotherapies ASX: IMU

(4:51)

Imugene (ASX: IMU) - Discussing IMU's 2022 Biotech Opportunity

(20:57)

Imugene Investor Webinar: MAST Study Update

(27:13)

Imugene's Presentation at the Capital HQ MasterClass

(6:35)

ELLIS- Ineligible

(9:41)

Biotech Unlocked - IMUGENE ASX:IMU

(18:36)

Imugene Investor Webinar with special guests Bradley Glover and Paul Woodard

(39:40)

Imugene thrilled as first patients dosed in VAXINIA MAST combination study

(5:15)

Imugene bringing effective new treatments and options to cancer patients

(11:25)

Imugene welcomes positive FDA feedback on new manufacturing process for azer-cel

(4:10)

Imugene's new cancer therapy CD19 (OnCARlytics) considered the 'Holy Grail'

(6:16)

Imugene's CEO interviewed on ausbiz detailing a clinical trial deal with Merck Germany and Pfizer.

(4:12)

Imugene Limited (ASX: IMU) Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO

(7:40)

Imugene welcomes dosing of first patient in nextHERIZON Phase 2 clinical trial

(5:20)

Imugene talks ABL partnership for VAXINIA and $80 million institutional capital raise

(4:50)

CAR T Explained

(3:58)

Imugene Investor Webinar | Acquisition of License for Azer-Cel Cell Therapy

(33:41)

A Californian Cancer Killer Professor Yuman Fong and his work with Imugene

(26:16)